| Literature DB >> 31918837 |
Juan Guido Chiabrando1, Aldo Bonaventura2, Alessandra Vecchié2, George F Wohlford3, Adolfo G Mauro4, Jennifer H Jordan5, John D Grizzard6, Fabrizio Montecucco7, Daniel Horacio Berrocal8, Antonio Brucato9, Massimo Imazio10, Antonio Abbate11.
Abstract
Pericarditis refers to the inflammation of the pericardial layers, resulting from a variety of stimuli triggering a stereotyped immune response, and characterized by chest pain associated often with peculiar electrocardiographic changes and, at times, accompanied by pericardial effusion. Acute pericarditis is generally self-limited and not life-threatening; yet, it may cause significant short-term disability, be complicated by either a large pericardial effusion or tamponade, and carry a significant risk of recurrence. The mainstay of treatment of pericarditis is represented by anti-inflammatory drugs. Anti-inflammatory treatments vary, however, in both effectiveness and side-effect profile. The objective of this review is to summarize the up-to-date management of acute and recurrent pericarditis.Entities:
Keywords: acute pericarditis; cardiac tamponade; constrictive pericarditis; recurrent pericarditis; treatment
Year: 2020 PMID: 31918837 DOI: 10.1016/j.jacc.2019.11.021
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094